Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  paclitaxel poliglumex
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-18 of 18 for your search:
Start Over
Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: GOG-0212, NCI-2009-00586, CDR0000422427, U10CA027469, NCT00108745
Phase III Randomized Study of Paclitaxel Poliglumex Versus Paclitaxel in Women With Chemotherapy-Naïve Stage IIIB or IV Non-Small Cell Lung Cancer and Performance Status 2
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other, Pharmaceutical / Industry
Protocol IDs: CTI-PGT305, CTI-PIONEER, NCT00269828
CT-2103 in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: GOG-0186C, NCI-2012-02493, CDR0000257039, U10CA027469, NCT00045682
Phase II CT-2103/Carboplatin in Ovarian Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: PGT201, NCT00069901
Paclitaxel Poliglumex and Capecitabine in Treating Patients With Metastatic Breast Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000456449, NCCTG-N0437, N0437, NCT00265733
Efficacy and Safety Study of Xyotax to Treat Prostate Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: PCa-X-02, 03-0192-05, NCT00446836
Phase II Study of Combination of Paclitaxel Poliglumex and Alimta for Advanced Non-small Cell Lung Cancer (NSCLC)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: D-0433, NCT00487669
Neoadjuvant Paclitaxel Poliglumex, Cisplatin and Radiation for Esophageal Cancer: A Phase II Trial (CTI#X64001)
Phase: Phase II
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: Other
Protocol IDs: BrUOG-E-215, NCT00522795
BrUOG-Brain-223:A Study of PPX (CT-2103), Temozolomide, and Concurrent Radiation for Newly Diagnosed Brain Tumors (CTI # CT2103)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: BrUOG-Brain-223, NCT00763750
PPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT Methylation
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: BrUOG 244, NCT01402063
Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: GOG-9914, NCI-2012-02532, CDR0000301642, U10CA027469, NCT00060359
CT-2103 in Combination With Gemcitabine in Metastatic Breast Cancer
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2005-0133, NCT00270907
A Pilot Study of PPX in Women With Metastatic Colorectal Cancer
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 3C-07-3, NCT00598247
Start Over